/China Resources Jiangzhong’s 2025 independent directors’ performance report (Wang Jinben)
NEWS

China Resources Jiangzhong’s 2025 independent directors’ performance report (Wang Jinben)

Shanghai Stock Exchange
2026/03/20

China Resources Jiangzhong Pharmaceutical Co., Ltd.

2025 Independent Directors’ Work Report

(Wang Jinben)

I have served as an independent director of China Resources Jiangzhong Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") since December 29, 2025. During my tenure, I have strictly complied with the "Company Law", "Securities Law", "Administrative Measures for Independent Directors of Listed Companies", "Articles of Association", "Independent Director System of the Company" and other relevant regulations, attended relevant meetings, carefully reviewed various proposals, and effectively safeguarded the legitimate rights and interests of the company and all shareholders. I now report on my performance of my duties as an independent director in 2025 as follows:

1. Basic situation

(1) Personal work resume, professional background and part-time job status

Wang Jinben, born in March 1966, is a member of the Democratic National Construction Association. Chinese nationality, no permanent residence abroad, master's degree in management, graduated from Jiangxi University of Finance and Economics (now Jiangxi University of Finance and Economics) majoring in accounting, obtained a bachelor's degree in economics, a master's degree in management, a senior accountant, and a Chinese certified public accountant. He once served as the deputy section chief and financial manager of the accounting and finance section of Jiangxi Textile Import and Export Company; the financial director of Hengdian Group High-tech Industry Co., Ltd.; the financial director of Zhejiang Zhejiang Wangxin Rand Technology Co., Ltd.; the general manager of Zhejiang Oasis Ecology Co., Ltd.; the independent director of Jiangxi Evergreen Co., Ltd.; the independent director of Jiangxi Evergrande High-tech Co., Ltd.; and the Jiangxi Zhongjiali High-tech Co., Ltd. Co., Ltd.; independent director of Huanong Hengqing Technology Co., Ltd.; independent director of Jiangxi Yum Intelligent Technology Co., Ltd.; independent director of Yunnan Bio Valley Pharmaceutical Co., Ltd.; independent director of Jiangxi Huangshanghuang Group Food Co., Ltd., independent director of Jiangxi Guoguang Commercial Chain Co., Ltd., independent director of Wanxiang Xinyuan Technology Co., Ltd., and external director of Jiangxi Building Materials Group Co., Ltd. Currently, he is an independent director of Jiangxi Ganfeng Lithium Industry Group Co., Ltd. and an independent director of Lianchuang Electronic Technology Co., Ltd. He will serve as an independent director of the company from December 29, 2025.

(2) Description of independence

During my tenure as an independent director of the company, I did not hold any position in the company other than as an independent director, nor did I hold any position in the company's major shareholder company. I have no interest relationship with the company or major shareholders or other relationships that may hinder my independent and objective judgment. My appointment complies with the independence requirements stipulated in the "Administrative Measures for Independent Directors of Listed Companies" and other regulations, and there are no circumstances that affect my independence.

2. Performance of duties in 2025

(1) Attendance at the board of directors and shareholders’ meetings

During my term of office, the company held a total of 1 board meeting. I participated in the meeting on-site, and after carefully reviewing all the proposals at the meeting, I voted in favor and did not vote against or abstain from voting.

(2) Attendance at special committees of the board of directors and special meetings of independent directors

I serve as the convener of the Audit Committee of the 10th Board of Directors of the company. In strict accordance with the relevant provisions of the Articles of Association and other relevant laws and regulations, I participated in one special committee of the Board of Directors and one special meeting of independent directors, and listened to the report on the 2025 annual financial statements and internal control integrated audit plan; no special powers were exercised.

(3) Communication with the internal audit institution and the accounting firm that undertakes the company’s audit business on the company’s financial and business status

I communicated with the accounting firm on the company's 2025 annual review work plan, time schedule, etc., and the relevant person in charge answered the questions I raised to ensure that I expressed independent and objective opinions on the company's annual report.

(4) On-site work and the company’s cooperation with independent directors

I took advantage of the opportunity to participate in the board of directors to conduct an on-site inspection of Jiangzhong Medicine Valley. During this period, I communicated with the company management and gained an in-depth understanding of the company's operations and actual progress in production technology innovation, digital transformation, R&D system construction and other fields. I also put forward opinions and suggestions on the research and development of classic famous recipes and the collaboration of research, production and marketing. Since I have served as an independent director of the company since December 29, 2025, my cumulative on-site working time in 2025 was less than 15 working days.

The company's directors, senior executives and relevant staff attach great importance to communication with independent directors, actively cooperate with and support my work, and effectively protect my right to know by organizing relevant meetings, timely delivering documents and materials, and reporting on the company's relevant operating conditions, etc., which provides good conditions and support for me to effectively perform the supervision and guidance responsibilities of independent directors.

3. Status of key matters for performance of duties in 2025

During my term of office, I carefully reviewed the resumes of the general manager, financial director and three deputy general manager candidates to be appointed by the company. After fully understanding their educational background, professional abilities, work experience and professional qualities, I believe that the candidates are qualified for the position.

4. Overall evaluation

Since serving as an independent director of the company, I have exercised my voting rights independently, objectively, fairly and prudently in accordance with the provisions and requirements of relevant laws, regulations and the company's relevant rules and regulations.

In 2026, I will strictly abide by relevant laws and regulations as well as the Articles of Association and other relevant provisions, and based on the principles of independence, objectivity and fairness, further strengthen communication and cooperation with the company's board of directors and management, effectively perform the duties of an independent director, and contribute to safeguarding the overall interests of the company and the legitimate rights and interests of all shareholders, especially small and medium-sized shareholders.

Finally, I would like to thank the company for its strong support and active cooperation in my work.